ZA200905677B - Protein formulations containing sorbitol - Google Patents
Protein formulations containing sorbitolInfo
- Publication number
- ZA200905677B ZA200905677B ZA200905677A ZA200905677A ZA200905677B ZA 200905677 B ZA200905677 B ZA 200905677B ZA 200905677 A ZA200905677 A ZA 200905677A ZA 200905677 A ZA200905677 A ZA 200905677A ZA 200905677 B ZA200905677 B ZA 200905677B
- Authority
- ZA
- South Africa
- Prior art keywords
- formulations containing
- protein formulations
- containing sorbitol
- sorbitol
- protein
- Prior art date
Links
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 239000000600 sorbitol Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90181107P | 2007-02-16 | 2007-02-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200905677B true ZA200905677B (en) | 2010-05-26 |
Family
ID=39402540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200905677A ZA200905677B (en) | 2007-02-16 | 2009-08-14 | Protein formulations containing sorbitol |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20080200655A1 (xx) |
| EP (1) | EP2124889A2 (xx) |
| JP (1) | JP2010519223A (xx) |
| KR (1) | KR20090110349A (xx) |
| CN (1) | CN101605532A (xx) |
| AU (1) | AU2008216090A1 (xx) |
| CA (1) | CA2675602A1 (xx) |
| IL (1) | IL199863A0 (xx) |
| MX (1) | MX2009008769A (xx) |
| RU (1) | RU2009127888A (xx) |
| WO (1) | WO2008101175A2 (xx) |
| ZA (1) | ZA200905677B (xx) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2527364A1 (en) * | 2007-03-29 | 2012-11-28 | Abbott Laboratories | Crystalline anti-human IL-12 antibodies |
| TWI661833B (zh) * | 2007-11-30 | 2019-06-11 | 百慕達商艾伯維生物技術有限責任公司 | 蛋白質調配物及製造其之方法 |
| US8883146B2 (en) | 2007-11-30 | 2014-11-11 | Abbvie Inc. | Protein formulations and methods of making same |
| MX2010012451A (es) | 2008-05-15 | 2010-12-07 | Baxter Int | Formulaciones farmaceuticas estables. |
| EP2399572A1 (en) * | 2010-06-22 | 2011-12-28 | Sandoz AG | Long-term storage of non-glycosylated recombinant human G-CSF |
| US9458484B2 (en) | 2010-10-22 | 2016-10-04 | Bio-Rad Laboratories, Inc. | Reverse transcriptase mixtures with improved storage stability |
| WO2012061448A1 (en) | 2010-11-04 | 2012-05-10 | Boehringer Ingelheim International Gmbh | Anti-il-23 antibodies |
| MX344727B (es) | 2010-11-11 | 2017-01-05 | Abbvie Biotechnology Ltd | Formulaciones liquidas de anticuerpos anti-tnf-alfa de alta concentracion mejoradas. |
| US11078265B2 (en) * | 2012-05-03 | 2021-08-03 | Boehringer Ingelheim International Gmbh | Anti-IL-23 antibodies |
| US11058768B2 (en) * | 2014-04-16 | 2021-07-13 | Biocon Ltd. | Stable protein formulations comprising a molar excess of sorbitol |
| WO2016014775A1 (en) | 2014-07-24 | 2016-01-28 | Boehringer Ingelheim International Gmbh | Biomarkers useful in the treatment of il-23a related diseases |
| WO2016036918A1 (en) | 2014-09-03 | 2016-03-10 | Boehringer Ingelheim International Gmbh | Compound targeting il-23a and tnf-alpha and uses thereof |
| BR112017014684A2 (en) | 2015-02-04 | 2018-01-09 | Boehringer Ingelheim International Gmbh | methods of treatment of inflammatory diseases |
| US20190046642A1 (en) | 2016-02-23 | 2019-02-14 | Eleven Biotherapeutics, Inc. | Il-6 antagonist formulations and uses thereof |
| CN110463819A (zh) * | 2019-09-16 | 2019-11-19 | 东北农业大学 | 一种通过电解及糖醇化合物改性米糠蛋白功能性质的方法 |
| US20240026332A1 (en) * | 2020-12-04 | 2024-01-25 | Amano Enzyme Inc. | Liquid enzyme preparation |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE148165T1 (de) * | 1989-07-24 | 1997-02-15 | Bayer Ag | Stabilisierung von hochgereinigten proteinen |
| ATE216590T1 (de) * | 1995-02-06 | 2002-05-15 | Genetics Inst | Arzneimittelformulierungen für il-12 |
| ATE454137T1 (de) * | 2001-07-25 | 2010-01-15 | Facet Biotech Corp | Stabile lyophilisierte pharmazeutische formulierung des igg-antikörpers daclizumab |
-
2008
- 2008-02-15 US US12/032,478 patent/US20080200655A1/en not_active Abandoned
- 2008-02-15 EP EP08729995A patent/EP2124889A2/en not_active Withdrawn
- 2008-02-15 KR KR1020097016981A patent/KR20090110349A/ko not_active Withdrawn
- 2008-02-15 JP JP2009550154A patent/JP2010519223A/ja not_active Withdrawn
- 2008-02-15 MX MX2009008769A patent/MX2009008769A/es not_active Application Discontinuation
- 2008-02-15 WO PCT/US2008/054110 patent/WO2008101175A2/en not_active Ceased
- 2008-02-15 RU RU2009127888/15A patent/RU2009127888A/ru unknown
- 2008-02-15 AU AU2008216090A patent/AU2008216090A1/en not_active Abandoned
- 2008-02-15 CA CA002675602A patent/CA2675602A1/en not_active Abandoned
- 2008-02-15 CN CNA2008800043349A patent/CN101605532A/zh active Pending
-
2009
- 2009-07-14 IL IL199863A patent/IL199863A0/en unknown
- 2009-08-14 ZA ZA200905677A patent/ZA200905677B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20090110349A (ko) | 2009-10-21 |
| CN101605532A (zh) | 2009-12-16 |
| MX2009008769A (es) | 2009-08-25 |
| IL199863A0 (en) | 2010-04-15 |
| RU2009127888A (ru) | 2011-03-27 |
| WO2008101175A3 (en) | 2009-01-08 |
| AU2008216090A1 (en) | 2008-08-21 |
| WO2008101175A2 (en) | 2008-08-21 |
| US20080200655A1 (en) | 2008-08-21 |
| CA2675602A1 (en) | 2008-08-21 |
| JP2010519223A (ja) | 2010-06-03 |
| EP2124889A2 (en) | 2009-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200905677B (en) | Protein formulations containing sorbitol | |
| EP1988922A4 (en) | PROTEIN FORMULATIONS | |
| GB2435419B (en) | Formulations | |
| EP2225275A4 (en) | PROTEIN FORMULATION | |
| EP2046930A4 (en) | FORMULATIONS BASED ON RHAMNOLIPIDS | |
| ZA200906699B (en) | Insecticidal proteins | |
| GB0711656D0 (en) | Formulations | |
| GB0716385D0 (en) | Formulations | |
| HUE046149T2 (hu) | Fehérje | |
| ZA200908969B (en) | Formulations | |
| IL211670A0 (en) | Therapeutic protein formulations | |
| GB0605780D0 (en) | Formulations | |
| GB0718409D0 (en) | Formulations | |
| GB0809979D0 (en) | Formulations | |
| GB0711957D0 (en) | Formulations | |
| GB0810232D0 (en) | Formulations | |
| GB0615108D0 (en) | Novel formulations | |
| GB0610336D0 (en) | Formulations | |
| GB0719231D0 (en) | Protein | |
| GB0718404D0 (en) | Formulations | |
| GB0711440D0 (en) | Aqueous formulations | |
| ZA200807682B (en) | Novel formulations | |
| GB0705179D0 (en) | Formulations | |
| GB0720563D0 (en) | Protein | |
| GB0710900D0 (en) | Formulations |